FEB 04, 2016 10:03 AM PST

Proton Therapy Zaps More Cancer, Less Healthy Cells

WRITTEN BY: Xuan Pham
Childhood brain cancers may fare better with proton beam therapy than conventional radiotherapies, say researchers from the Massachusetts General Hospital (MGH). Their latest study was recently published in The Lancet Oncology.
 
Proton therapy for cancer has less side effects

Medulloblastoma is of the most common and deadly form of pediatric brain cancer. The malignant tumor cells rapidly grow out of control at the base of the brain, near the cerebellum. There, they aggressively metastasize through the cerebral spinal fluid to other locations on the brain and spine cord. Once the medulloblastoma spreads, the five-year survival rate drops to about 60%.
 
Though catching and treating the cancer early is generally considered a good thing, medulloblastoma treatments have so far been a double-edged sword for the pediatric patients. Once diagnosed, the children typically undergo surgeries for removal, followed by intense photon radiotherapy and chemotherapy. These treatments kill the cancer cells, but they also kill the healthy cells in the children’s fragile but rapidly growing brains. Patients often develop cognitive deficits along with other organ problems as a due to radiation exposure. As a result, earlier treatments are often associated with severe long-term side effects.
 
To reduce the collateral damages to healthy brain cells, researchers turned to proton therapy. Also known as proton beam therapy, the treatment uses the ionizing power of protons to damage the DNA of cancer cells, and thus kill them. X-rays do the same thing, but proton beams can do it in a more targeted fashion, reducing the amount of damage to healthy cells.
 
 
Led by Dr. Torunn Yock of MGH, the research team evaluated the outcome of proton therapy in children with medulloblastomas. All 59 patients had surgeries to remove the tumors, and then were subsequently treated with proton beam therapy. Patients also received chemotherapy in conjunction with the proton treatment. Researchers charted the patients’ response to the treatments over the course of 8 years.
 
Though they found that though proton therapy didn’t improve patient survival rates, the side effects were reduced. For example, at five years post treatment, 16% of patients displayed hearing loss, compared to the 25% reported in studies using conventional radiotherapy.
 
Other cognitive functions, such as verbal comprehension and processing speed, though affected, were not as deficient than that reported with photon therapy. Most significantly, the children who received proton therapy did not have any side effects in the heart, lungs, or intestines. These organs are commonly affected in traditional photon therapies.
 
The findings show that proton beam treatment is as effective as traditional methods, but is less toxic to the patients.

"I truly believe that - particularly for the youngest children - the ability to offer them proton therapy can make a big difference in their lives." – Dr. Yock, senior study author.

Additional sources: MNT
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
DEC 09, 2019
Clinical & Molecular DX
DEC 09, 2019
Astronauts help to advanced personalized medicine
Extreme temperatures and lethal levels of radiation are just some of the hazards faced by astronauts as they traverse th ...
JAN 07, 2020
Clinical & Molecular DX
JAN 07, 2020
Saliva Test for Early Detection of Mouth and Throat Cancer
“OPC is one of the fastest rising cancers in Western countries due to increasing HPV-related incidence, especially ...
MAR 29, 2020
Cancer
MAR 29, 2020
MicroRNA as a New Way to Test for Lung Cancer
The most common, and most deadly, cancer across the world is lung cancer. If caught early, lung cancer has quite a low m ...
APR 22, 2020
Drug Discovery & Development
APR 22, 2020
Only 3% of COVID-19 Antibody Tests Approved by FDA
So far, only 3% of at least 90 COVID-19 antibody tests in the US have been approved by the Food and Drug Administration ...
APR 21, 2020
Clinical & Molecular DX
APR 21, 2020
New Diagnostic FET-based Biosensor Enables Rapid Detection of SARS-CoV-2
The coronavirus disease 2019 (COVID-19) pandemic continues to be at the forefront of the World’s attention. COVID- ...
APR 29, 2020
Clinical & Molecular DX
APR 29, 2020
Move and Detect : Diagnosis of Neonatal Sepsis Using Fluorescent Micromotors
According to the World Health Organization (WHO), sepsis occurs when the body’s response to an infection injures i ...
Loading Comments...